Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00561925
What this trial is testing

VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 1,068
Large-scale testing (Phase 3)Study completedNCT02006745
What this trial is testing

Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

Who this might be right for
HIV
St Stephens Aids Trust 20
Not applicableEnded earlyNCT00001064
What this trial is testing

A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT00540449
What this trial is testing

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Who this might be right for
HIV InfectionsHIV-1Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 694
Testing effectiveness (Phase 2)Ended earlyNCT00002418
What this trial is testing

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Who this might be right for
HIV Infections
Bristol-Myers Squibb 25
Not applicableStudy completedNCT00002398
What this trial is testing

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Gilead Sciences
Post-approval studies (Phase 4)Study completedNCT00002179
What this trial is testing

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 200
Testing effectiveness (Phase 2)Study completedNCT00000925
What this trial is testing

Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss

Who this might be right for
HIV InfectionsHIV Wasting Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT02527096
What this trial is testing

A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 110
Large-scale testing (Phase 3)Study completedNCT01252940
What this trial is testing

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Who this might be right for
HIV-1 Infection
Gilead Sciences 482
Not applicableNot Yet RecruitingNCT06582797
What this trial is testing

Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor

Who this might be right for
HIV-1-infection
University of Kansas Medical Center 10
Large-scale testing (Phase 3)UnknownNCT00005002
What this trial is testing

Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 688
Early research (Phase 1)Study completedNCT01071031
What this trial is testing

HIV Vaccine Study in HIV Positive Patients

Who this might be right for
HIV Infections
PepTcell Limited 54
Testing effectiveness (Phase 2)Study completedNCT02054286
What this trial is testing

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

Who this might be right for
HIV Infection
Theravectys S.A. 38
Post-approval studies (Phase 4)UnknownNCT02370979
What this trial is testing

Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients

Who this might be right for
HIV-1 Infection
University Hospital, Strasbourg, France 202
Not applicableStudy completedNCT03957369
What this trial is testing

Primary Resistance in HIV Patients in Colombia

Who this might be right for
HIV Infection
Fundacion REVIVA, Red de VIH del Valle del Cauca 527
Post-approval studies (Phase 4)Study completedNCT03757117
What this trial is testing

Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade

Who this might be right for
HIV-1-infection
Asociación Civil Impacta Salud y Educación, Peru 220
Large-scale testing (Phase 3)Study completedNCT00002397
What this trial is testing

Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease

Who this might be right for
HIV InfectionsAIDS-Associated Nephropathy
Hoffmann-La Roche 24
Not applicableNot Yet RecruitingNCT07569913
What this trial is testing

Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test

Who this might be right for
HIV1 InfectionHIV 2 InfectionSyphilis Infection+1 more
bioLytical Laboratories 500
Post-approval studies (Phase 4)UnknownNCT03549312
What this trial is testing

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy

Who this might be right for
HIV-1-infectionHepatitis C, ChronicMethadone Dependence+6 more
Saskatchewan Health Authority - Regina Area 25
Next Page